Dawnrays Pharmaceutical (Holdings) Limited is an investment holding company that develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments: Intermediates and Bulk Medicines, and Finished Drugs. Its products include antibiotics such as pharmaceutical intermediates, bulk medicines, powder for injections, cephalosporin tablets, and other oral solid-dosage-form antibiotics, as well as system-specific medicines for therapeutic areas including cardiovascular, anti-HBV, anti-allergic, digestive, urinary, anti-hypertensive, antihyperlipidemic, antiviral, and endocrine systems. Founded in 1995, the company is headquartered in Wan Chai, Hong Kong.